HCPCS Codes Similar to G9844

HCPCS Codes Similar to “G9844” Code.
Patient did not receive anti-egfr monoclonal antibody therapy

G9839 Anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9845 Patient received anti-egfr monoclonal antibody therapy Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
M0235 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON
Q0235 Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	S9562 Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem Code added date: 20030101 Code effective date: 20230401 TXT \| PDF \| XML \| JSON
G9840 Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9841 Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab Code added date: 20170101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1189 Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
M1190 Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	J7505 Muromonab-cd3, parenteral, 5 mg Code added date: 19880101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
M1233 Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	G9777 Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON